Clinical Trial: A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD

U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07351734) titled 'A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD' on Jan. 10.

Brief Summary: The goal of this clinical trial is to learn if drug JKN2403 works to treat moderate-to-severe COPD in adults. It will also learn about the safety and pharmacokinetic characteristics of drug JKN2403. The main questions it aims to answer are:

Does drug JKN2403 reduce the incidence of AECOPD or improve the quality of life or alleviate symptoms related to COPD?

Researchers will compare drug JKN2403 to a placebo (a look-alike substance that contains no drug) to see if drug JKN2403 works to treat moderate-to-severe COPD.

Parti...